Prevest DenPro Limited has successfully concluded its board meeting held on February 14, 2026, approving the unaudited financial results for the quarter ended December 31, 2025. The meeting, which commenced at 03:30 p.m. and concluded at 04:05 p.m., addressed key regulatory compliance matters as previously scheduled.

Board Meeting Outcomes

The board of directors transacted and approved the following business matters during the meeting:

Statutory Auditor's Review

Mittal & Associates, Chartered Accountants (FRN: 106456W), conducted the limited review of both standalone and consolidated financial results. Partner Sourabh Bagaria (Membership No 183850) signed the review reports, confirming compliance with Accounting Standard 25 Interim Financial Reporting and SEBI Listing Regulations.

Consolidated Financial Structure

The consolidated financial results include the following entities under the group structure:

The auditor's report specifically mentions that Axiodent Inc. contributed total revenues of ₹10.24 lakhs for the quarter, while Prevest Denpro Gulf General Trading LLC reported no revenue during this period.

Regulatory Compliance

Company Secretary and Compliance Officer Aman Sadhotra digitally signed the regulatory communication, ensuring proper documentation and compliance with BSE requirements. The company trades on BSE SME platform under scrip number 543363 with the symbol PREVEST.

The unaudited financial results and statutory auditor's limited review reports have been submitted to BSE Limited for record and dissemination to all stakeholders as required under SEBI regulations.

Prevest Denpro Limited, a leading dental products company, has reported impressive financial results for the first half of fiscal year 2026, showcasing robust growth and setting ambitious targets for the future.

Financial Highlights

Prevest Denpro's performance in H1 FY26 demonstrates its resilience and strong market position in the dental products industry. The maintenance of a healthy EBITDA margin at 39.04% indicates efficient cost management and operational effectiveness.

Growth Drivers

Prevest Denpro's impressive results can be attributed to several key factors:

1. Digital Dentistry Solutions: The company's focus on innovative digital dentistry products is contributing significantly to its growth.

2. 3D Printing Products: Expansion in the 3D printing segment is opening up new revenue streams and market opportunities.

3. US Market Expansion: Through its subsidiary Axiodent, Prevest Denpro is making strides in the US market, driving export revenue growth.

Future Outlook

Prevest Denpro has set a target to cross Rs 100 crore in revenue within the next three years. This goal reflects the company's confidence in its growth strategy and market potential.

Expert Commentary

Radhika Sahani, a fintech and markets expert, comments on Prevest Denpro's performance:

"Prevest Denpro's strong H1 FY26 results showcase the company's ability to capitalize on the growing demand for advanced dental solutions. The focus on digital dentistry and 3D printing aligns well with the industry's shift towards more technologically advanced products. The robust export growth, particularly in the US market, indicates successful market penetration strategies. However, investors should keep an eye on how the company maintains its impressive EBITDA margins while pursuing aggressive growth targets."

As the dental industry continues to evolve with technological advancements, Prevest Denpro seems well-positioned to capitalize on these trends. The company's performance in the coming quarters will be crucial in determining its trajectory towards the Rs 100 crore revenue target.